---
title: "ALMAC - active and placebo capsule manufacture for the LAMDARCT Clinical Trial"
ocid: "ocds-h6vhtk-058571"
canonical_url: "https://d3tenders.com/contract/?ocid=ocds-h6vhtk-058571"
markdown_url: "https://d3tenders.com/contract/ocds-h6vhtk-058571.md"
json_url: "https://d3tenders.com/contract/ocds-h6vhtk-058571.json"
source: "Find A Tender Service"
current_stage: "Award"
buyer: "BELFAST HEALTH & SOCIAL CARE TRUST"
published: "2025-12-08"
---

# ALMAC - active and placebo capsule manufacture for the LAMDARCT Clinical Trial

Buyer: BELFAST HEALTH & SOCIAL CARE TRUST  
Current stage: Award  
OCID: ocds-h6vhtk-058571

[View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-h6vhtk-058571)  
[Download OCDS JSON](https://d3tenders.com/contract/ocds-h6vhtk-058571.json)

## Summary

The Belfast Health & Social Care Trust initiated a procurement process for the manufacture of active and placebo capsules for the LAMDARCT Clinical Trial, under the legal framework of the UK Public General Acts 2023. The title of this procurement is "ALMAC - active and placebo capsule manufacture for the LAMDARCT Clinical Trial", and its main procurement category is goods within the pharmaceutical industry, located in the United Kingdom. Originally, the procurement was set as a direct award to ALMAC Clinical Services Limited, with a contract period from 1st November 2025 to 1st November 2029. Due to changes in start dates, value, and scope, the initial contract was cancelled on 8th December 2025, and new notices (UK5 and UK6) are to be published for the revised tender.

This procurement represents significant business growth opportunities by catering to the niche market of clinical trial supplies, especially the pharmaceutical segment focusing on innovative and cost-effective treatments for conditions such as age-related macular degeneration. Large pharmaceutical manufacturers with expertise in producing clinical trial materials and possessing the necessary MHRA licensing would be well-suited to compete. Being adept in delivering complex pharmaceutical products on a larger scale will also be a competitive advantage for suppliers interested in participating in the revised procurement process.

## Notice

This procurement if for active and placebo capsule manufacture for the LAMDARCT Clinical Trial .

### Procurement Information

Schedule 5, (2) The public contract concerns the production of a prototype, or supply of other novel goods or services, for the purpose of (c) other research, experiment, study or development. Age-related macular degeneration (AMD) is a leading cause of visual loss. There are two main forms of AMD: dry and wet. The current wet AMD treatment is intravitreal antiVEGF injections, repeated every 4-12 weeks. Due to the cost of the medication, the route and frequency of administration, this treatment is a significant burden on the NHS budget.An additional treatment option for wet AMD is L-dopa. L-dopa is a widely available drug (used in treatment of Parkinson's), typically in the form of Carbidopa-L-Dopa. It is taken as an oral tablet and is significantly cheaper than the antiVEGF injections. The study will be a placebo-controlled clinical trial. Eligible patients will be randomised to receive either 100mg L-DOPA+25mg carbidopa or placebo twice a day, for 24 months, in addition to the current standard of care to determine if this is a more cost-effective and easier-to-administer treatment regime than the current standard of care. To 'blind' this clinical trial (to reduce bias) requires the development and manufacture of over encapsulated 100mg L-DOPA+25mg carbidopa tablets and development and manufacture of matching placebo capsules. The expertise required to develop and manufacture these capsules in the quantity required for this trial requires outsourcing to a manufacturer licensed by the MHRA possessing the necessary technical expertise.

## Key Details

| Field | Value |
| --- | --- |
| Publication source | Find A Tender Service |
| Latest notice | https://www.find-tender.service.gov.uk/Notice/080707-2025 |
| Notice type | UK6 - Contract Award Notice |
| Procurement type | Standard |
| Procurement category | Goods |
| Procurement method | Direct |
| Procurement method details | Direct award |
| Tender suitability | Not specified |
| Awardee scale | Large |
| All stages | Tender, Award |

## Dates

| Field | Value |
| --- | --- |
| Publication date | 8 Dec 2025 |
| Submission deadline | Not specified |
| Future notice date | Not specified |
| Award date | 10 Aug 2025 |
| Contract period | 1 Nov 2025 - 1 Nov 2029 |
| Recurrence | Not specified |

## Values

| Field | Value |
| --- | --- |
| Tender value | Not specified |
| Lots value | Not specified |
| Awards value | £416,789 |
| Contracts value | Not specified |

## Status

| Field | Value |
| --- | --- |
| Tender status | Complete |
| Lots status | Complete |
| Awards status | Active |
| Contracts status | Cancelled |

## Buyer

| Field | Value |
| --- | --- |
| Main buyer | BELFAST HEALTH & SOCIAL CARE TRUST |
| Additional buyers | Missing |
| Locality | BELFAST |
| Post town | Northern Ireland |
| Postcode | BT12 6BA |
| Country | Northern Ireland |
| ITL 1 | TLN Northern Ireland |
| ITL 2 | TLN0 Northern Ireland |
| ITL 3 | TLN06 Belfast |
| Local authority | Belfast |
| Electoral ward | Falls |
| Westminster constituency | Belfast West |
| Delivery location | Not specified |

## Supplier

| Field | Value |
| --- | --- |
| Number of suppliers | 1 |
| Supplier names | ALMAC CLINICAL SERVICES |

## CPV Codes

### Divisions

- 33 - Medical equipments, pharmaceuticals and personal care products

### Codes

- 33600000 - Pharmaceutical products

## Release History

- 8 Dec 2025 at 15:19 - TenderCancellation - UK12 - Procurement Termination Notice - https://www.find-tender.service.gov.uk/Notice/080707-2025
- 11 Aug 2025 at 15:30 - Award - UK6 - Contract Award Notice - https://www.find-tender.service.gov.uk/Notice/047756-2025
- 11 Aug 2025 at 15:13 - Award - UK5 - Transparency Notice - https://www.find-tender.service.gov.uk/Notice/047749-2025

## Documents

- https://www.find-tender.service.gov.uk/Notice/080707-2025
  8th December 2025 - Procurement termination notice on Find a Tender
- https://www.find-tender.service.gov.uk/Notice/047756-2025
  11th August 2025 - Contract award notice on Find a Tender
- https://www.find-tender.service.gov.uk/Notice/047749-2025
  11th August 2025 - Transparency notice on Find a Tender

## Notice URLs

- http://ww.almacgroup.com
- https://www.legislation.gov.uk/ukpga/2023/54/contents

## Provenance

This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-h6vhtk-058571. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-h6vhtk-058571.json.